US/UK/Canada

Share

Contacts

  • Morten Henneveld

    CEO


    +46 18 55 39 93

    • Links

    Pick a time period -
    Tags ( Active)

    New preclinical data shows that OssDsign’s innovative synthetic bone graft outperforms a comparable device in bone formation following spinal fusion surgery

    OssDsign AB (publ) (“OssDsign” or the “Company”) today announced that the recently aquired orthobiological product OssDsign Catalyst (previously named Osteo[3] ZP Putty) has been evaluated in a preclinical study examining bone formation and function following spinal fusion surgery. The results show that OssDsign Catalyst induced rapid and reliable bone formation and that successful fusion was achieved in 100% of the studied subjects at 26 weeks, compared to 60% in the group where a comparable market-cleared device was used.OssDsign develops patient-specific regenerative implants aimed at

    New scientific paper further confirms osteointegration of OssDsign Cranial PSI implants

    OssDsign AB (publ) (“OssDsign” or the “Company”) today announced that independent researchers from Uppsala University Hospital, Sweden, have published a scientific paper in Journal of Neurosurgery describing bone integration in patients implanted with OssDsign Cranial PSI. Samples from four studied patients consistently show vascularized bone, integrating the OssDsign implant with surrounding native bone. This reaffirms the positive findings presented in previously published papers and further strengthens the benefits of OssDsign’s custom-made calcium phosphate implants.Patients undergoing

    New publication in high-impact scientific journal PNAS confirms the bone regenerative potential of OssDsign’s technology.

    A scientific article titled “In situ bone regeneration of large cranial defects using synthetic ceramic implants with a tailored composition and design” was recently published in the scientific journal PNAS (Proceedings of the National Academy of Sciences of the United States of America). The research article describes how OssDsign’s unique implant concept and proprietary material composition promote bone regeneration and osseointegration.OssDsign AB (publ) (“OssDsign”) today announced that a scientific article with the title “In situ bone regeneration of large cranial defects using

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media